speakers

The ChinaBio® Investor Forum features speakers from the US and China that are renowned experts in their fields, including:

• The State of the China Biotech Industry - China's biotech and life science industry is rapidly becoming a global force.  And it is the fastest growing industry segment in VC investment.
• Attacting Capital - Learn what US and China investors are looking for in early and mid-stage biotechnology, diagnostics and services companies, and hear entrepreneurs tell their success stories.
• Challenges and Legal Issues - Many challenges face the entrepreneur and investor including China's new labor laws and investment policies, the Foreign Corrupt Practices Act, IP transfer limitations, corporate structure, etc.
• Partnering in China - How to reduce your costs and improve the return on investment by partnering with major pharma or using CROs and CMOs in China to perform much of the work in drug development. 
   

Speaker List

The following industry experts will be providing insights into China's emerging biotechnology industry and how to launch and build a successful life science companies at the ChinaBio® Investor Forum.  (Click here for Speaker Bios.)

Keynote Speakers:

The State of China Biotech
Greg B. Scott – President and Founder, ChinaBio Accelerator

Creating a Successful Biotech Cluster
Ian Wisenberg – Senior Vice President/CFO, BIOCOM

Speakers and Panelists:

• Bo Wen, MBA - Executive Director, The Balloch Group
• Tony Chen, JD - Partner, Jones Day
• Rachel Gong, PhD, MBA - Morningside Ventures
• Jennifer Hu, PhD - Director of Licensing & External Research, Merck & Co.
• Walter Lau, PhD - Vice President, Fidelity Asia Ventures
• Nisa Leung, MBA - Partner, Qiming Venture Partners
• Chuck Ng - Managing Director, Hambrecht Suma Capital
• Hongbo B. Lu, PhD - VP and Senior Research Analyst, Piper Jaffray & Co.
• John V. Olyer, MBA - President and CEO, BioDuro, Inc.
• R. Stephen Porter, PhD - CSO, Medicilon-MPI Preclinical Research
• Wayne Shiong - Partner, WI Harper Group
• Alex Wu, PhD, MBA - CEO, Crown Bioscience, Inc.
• John Zhu, PhD, MBA - Executive Director, Mingly China Growth Fund
• Chika Yoshinaga, MD – Vice President of Asia, Sofinnova Partners
• Xumu Zhang, PhD - CTO, Chiral Quest, Inc.
• Wei Zhou, PhD, JD – Partner, WSGR
• James Zhu, PhD, JD – Partner, Perkins Coie LLP

Presenting Companies

Twenty companies with novel technologies from throughout China will present at the ChinaBio® Investor Forum in Beijing: 10 drug development, 5 services, 3 device and 1 drug delivery. All presenting companies have been screened by ChinaBio to ensure high quality presentations.

For a more detailed list, please click here.

• 2Y-Chem - Shanghai (Services)
• A&F Biopharm - Suzhou (Diagnotics)
• Avolix Pharmaceuticals - China/USA (Drug)
• Baofa Cancer - Shandong (Drug)
• Bio-Cancer Treatment - Hong Kong (Drug)
• CK Life Sciences - Hong Kong (Drug)
• FortuneRock - Tianjin (Drug)
• Fountain Medical - Tianjin/USA (Services)
• Innovia - China/USA (Device)
• Kambridge Life Science - Beijing (Delivery)
• Laviana - China/USA (Services)
• Nanopack Technology - Suzhou (Device)
• NeWave Biosciences - China/US (Drug)
• Protelight/BioAMPs - Changchun/USA (Drug)
• Renew BioCare - Shanghai (Device)
• RxD BioPharma - Suzhou (Drug)
• Sanlugen Pharmatech - Jinan/USA (Services)
• VenturePharm - Beijing (Services)
• Yes Biotech - Suzhou/Canada (Drug)
• Zhejiang Cell - Hangzhou (Drug)